|
|
|
|
| Audio |
 |
|
|
|
| Calendar |
|
/ February 27–28, 2020: Pharmaceutical Compliance Congress Asia / |
|
Kyoto, Japan |
|
/ March 8-11, 2020: Pharma Forum 2020 / |
|
New York City, NY |
|
/ March 18–19 2020: World Pharma Pricing Market Access & Evidence Congress / |
|
Amsterdam, The Netherlands |
|
/ March 18–19, 2020: World Pharma Pricing Market Access & Evidence Congress / |
|
Amsterdam, The Netherlands |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress / |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020 / |
|
Barcelona, Spain |
|
|
| Industry update |
| //Santhera Pharmaceuticals (Pratteln, Switzerland) announced the appointment of Andrew Smith as Chief Financial Officer and member of the Executive Management team, effective April 1, 2020.
//Pawel Rosikiewicz, co-Founder of SwissAI Machine Learning Meetups and the SwissAI foundation, joined GenomSys (Lausanne, Switzerland) as Scientific Communications Expert.
//Inceptua Group (Luxembourg) named Philip Gregory as Vice President, Head of Asia-Pacific, Clinical Trial Services.
//Crescendo Biologics (Cambridge, UK) appointed Dr, Kenji Hashimoto as Chief Medical Officer.
//The Board of the Cell and Gene Therapy Catapult (London, UK) has announced that its new Chief Executive Officer will be Matthew Durdy, currently the organization’s Chief Business Officer. The appointment will be effective from April 2020.
//Centrient Pharmaceuticals (Rotterdam, The Netherlands) announced that Karl Rotthier is stepping down as CEO after leading the company for ten years. The Board of Directors has named Rex Clements as the new CEO, effective March 16, 2020.
//Affimed (Heidelberg, Germany) announced that its Chief Financial Officer, Dr. Florian Fischer, has passed away due to complications related to neoplasia.
|
|
|
|
|
|
|
|
|
Register Now
